A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer
Conditions
Carcinoma
Conditions: official terms
Carcinoma, Non-Small-Cell Lung
Conditions: Keywords
carcinoma, breast cancer, non-small cell lung cancer, ovarial cancer, ambulant chemotherapy, treatment cycles, Paclitaxel, Paclitaxel onkovis, Quantity of Paclitaxel, Packaging Sizes
Study Type
Observational
Study Phase
N/A
Study Design
Time Perspective: Prospective
Overall Status
Recruiting
Summary
The main purpose of this observational study with Paclitaxel is to determine the number of treatment cycles and the quantity of Paclitaxel onkovis needed therefore under the special circumstance of ambulant chemotherapy.

onkovis aims an economical utilization of the chemotherapeutics.The provision with adapted packaging sizes as to decrease the excess quantity to be discarded follows also this objective.

Secondary objectives are the survey of the side effects of Paclitaxel onkovis in comparison to Docetaxel. To this purpose, data regarding co medications and adverse events are also collected.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: N/A
Gender: Both
Criteria: Inclusion Criteria:

- Indication for Paclitaxel according to the SmPC and treating physician

Exclusion Criteria:

- according to the Paclitaxel SmPC
Locations
Practice
Brandenburg, Germany
Status: Recruiting
Practice
Chemnitz, Germany
Status: Recruiting
Practice
Dresden, Germany
Status: Recruiting
Practice
Mühlhausen, Germany
Status: Recruiting
Practice
Plauen, Germany
Status: Recruiting
Start Date
August 2012
Completion Date
May 2016
Sponsors
Onkovis GmbH
Source
Onkovis GmbH
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page